UPDATE: Syros Pharmaceuticals (SYRS) PT Raised to $23 at Roth Capital
Tweet Send to a Friend
(Updated - September 23, 2021 8:27 AM EDT)
Roth Capital analyst Zegneh Jallah raised the price target on Syros ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Roth Capital analyst Zegneh Jallah raised the price target on Syros ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
